The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.




Skip slideshow


free access

Myeloid‐derive suppressor cells in the therapy of autoimmune diseases

  •  25 September 2023

Graphical Abstract

Description unavailable

The role of myeloid-derived suppressor cells (MDSCs) in autoimmunity is unclear. Reviewed studies suggest that MDSCs can be pathogenic or beneficial, depending on the disease stage and underlying mechanisms. The therapeutic potential of MDSCs could be harnessed in well-controlled cell therapy or direct expansion and activation of MDSCs in vivo.

More articles

The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.

More articles

Latest news